Nu Skin Enterprises, Inc. (NYSE:NUS) has been given a consensus rating of “Hold” by the ten research firms that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a sell rating and six have issued a buy rating on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $76.86.
A number of analysts recently weighed in on NUS shares. Zacks Investment Research downgraded Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Thursday, December 20th. ValuEngine downgraded Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Wednesday, March 20th. Bank of America set a $65.00 price target on Nu Skin Enterprises and gave the company a “sell” rating in a research note on Friday, March 1st. Pivotal Research restated a “buy” rating and issued a $85.00 price target on shares of Nu Skin Enterprises in a research note on Wednesday, March 13th. Finally, Stifel Nicolaus downgraded Nu Skin Enterprises from a “hold” rating to a “sell” rating and decreased their price target for the company from $63.00 to $43.00 in a research note on Monday, March 25th.
A number of institutional investors and hedge funds have recently bought and sold shares of NUS. Bank of New York Mellon Corp boosted its position in Nu Skin Enterprises by 0.4% during the third quarter. Bank of New York Mellon Corp now owns 820,216 shares of the company’s stock worth $67,601,000 after purchasing an additional 3,213 shares in the last quarter. Martingale Asset Management L P lifted its position in shares of Nu Skin Enterprises by 10.8% in the third quarter. Martingale Asset Management L P now owns 158,105 shares of the company’s stock valued at $13,032,000 after acquiring an additional 15,450 shares in the last quarter. Franklin Resources Inc. lifted its position in shares of Nu Skin Enterprises by 69.5% in the third quarter. Franklin Resources Inc. now owns 6,461 shares of the company’s stock valued at $533,000 after acquiring an additional 2,650 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Nu Skin Enterprises in the third quarter valued at $224,000. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Nu Skin Enterprises in the third quarter valued at $259,000. Institutional investors own 76.15% of the company’s stock.
Shares of NYSE:NUS traded down $0.20 during trading on Thursday, reaching $49.68. The company had a trading volume of 11,135 shares, compared to its average volume of 807,058. The firm has a market cap of $2.76 billion, a P/E ratio of 14.14, a PEG ratio of 1.20 and a beta of 0.65. The company has a current ratio of 1.82, a quick ratio of 1.15 and a debt-to-equity ratio of 0.46. Nu Skin Enterprises has a fifty-two week low of $44.36 and a fifty-two week high of $88.68.
Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Wednesday, February 13th. The company reported $1.05 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $1.05. The business had revenue of $683.29 million for the quarter, compared to analyst estimates of $676.76 million. Nu Skin Enterprises had a return on equity of 25.98% and a net margin of 4.55%. The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.20 earnings per share. Research analysts forecast that Nu Skin Enterprises will post 3.87 EPS for the current fiscal year.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Further Reading: How is an ETF different from a mutual fund?